Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neonatal polycythemia.

L C Schussman, S T Wright

    American Family Physician
    |February 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Neonatal polycythemia, a condition affecting 2-12% of newborns, can cause serious neurologic issues. Treatment is crucial for infants with high hematocrits to prevent long-term complications.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Risk factors associated with incident sexually transmitted infections in HIV-positive patients in the Australian HIV Observational Database: a prospective cohort study.

    HIV medicine·2016
    Same author

    HLA Matching at the Eplet Level Protects Against Chronic Lung Allograft Dysfunction.

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2016
    Same author

    HIV and aging: insights from the Asia Pacific HIV Observational Database (APHOD).

    HIV medicine·2014
    Same author

    An increase in the "inhibitor-β" content of detached wheat leaves following a period of wilting.

    Planta·2014
    Same author

    The relationship between leaf water potential ψ leaf and the levels of abscisic acid and ethylene in excised wheat leaves.

    Planta·2014
    Same author

    The effect of 6-benzyladenine and leaf ageing treatment on the levels of stress-induced ethylene emanating from wilted wheat leaves.

    Planta·2014
    Same journal

    For Post-stent Patients With Atherosclerotic Coronary Vascular Disease Who Are Taking an Anticoagulant, Adding Aspirin Worsens Outcomes.

    American family physician·2026
    Same journal

    Nausea and Vomiting During Pregnancy.

    American family physician·2026
    Same journal

    Metabolic Dysfunction-Associated Steatotic Liver Disease: Diagnosis and Management.

    American family physician·2026
    Same journal

    Aerobic Exercise Is the Better Exercise Modality for Knee Osteoarthritis.

    American family physician·2026
    Same journal

    Overscreening Leads to Overdiagnosis of MASLD.

    American family physician·2026
    Same journal

    Type 2 Diabetes: Outpatient Insulin Management.

    American family physician·2026
    See all related articles

    Area of Science:

    • Neonatology
    • Pediatrics
    • Hematology

    Background:

    • Neonatal polycythemia affects 2-12% of newborns.
    • Potential causes include placental transfusion, insufficiency, congenital abnormalities, and endocrine/metabolic disorders.
    • Blood hyperviscosity in polycythemia can lead to permanent neurologic impairment.

    Purpose of the Study:

    • To highlight the incidence and causes of neonatal polycythemia.
    • To emphasize the necessity of treating this condition due to potential neurologic complications.
    • To outline the recommended treatment threshold for reduction transfusion.

    Main Methods:

    • Review of existing literature on neonatal polycythemia.
    • Analysis of associated conditions and risk factors.

    Related Experiment Videos

  • Identification of diagnostic criteria and treatment indications.

    • Main Results:

    • Polycythemia incidence ranges from 2% to 12% in newborns.
    • Associated conditions span placental factors to congenital and metabolic disorders.
    • Central hematocrit levels exceeding 65% warrant intervention.

    Conclusions:

    • Neonatal polycythemia requires prompt recognition and management.
    • Reduction transfusion is indicated for hematocrits over 65% to mitigate risks.
    • Early treatment is vital to prevent adverse neurologic outcomes.